Multitarget disease-modifying therapy in Parkinson's disease?

被引：13

作者：

Calabresi, Paolo ^{[1
,2
]}

Di Filippo, Massimiliano ^{[1
]}

机构：

[1] Univ Perugia, Osped Santa Maria Misericordia, Neurol Clin, Dept Med, I-06156 Perugia, Italy

[2] IRCCS Fdn Santa Lucia, Rome, Italy

来源：

LANCET NEUROLOGY | 2015年 / 14卷 / 10期

关键词：

D O I：

10.1016/S1474-4422(15)00227-6

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：975 / 976

页数：3

共 10 条

[1] Direct and indirect pathways of basal ganglia: a critical reappraisal [J].

Calabresi, Paolo ;

Picconi, Barbara ;

Tozzi, Alessandro ;

Ghiglieri, Veronica ;

Di Filippo, Massimiliano .

NATURE NEUROSCIENCE, 2014, 17 (08) :1022-1030

[2] LRRK2 kinase activity regulates synaptic vesicle trafficking and neurotransmitter release through modulation of LRRK2 macro-molecular complex [J].

Cirnaru, Maria D. ;

Marte, Antonella ;

Belluzzi, Elisa ;

Russo, Isabella ;

Gabrielli, Martina ;

Longo, Francesco ;

Arcuri, Ludovico ;

Murru, Luca ;

Bubacco, Luigi ;

Matteoli, Michela ;

Fedele, Ernesto ;

Sala, Carlo ;

Passafaro, Maria ;

Morari, Michele ;

Greggio, Elisa ;

Onofri, Franco ;

Piccoli, Giovanni .

FRONTIERS IN MOLECULAR NEUROSCIENCE, 2014, 7

[3] Ageing as a primary risk factor for Parkinson's disease: evidence from studies of non-human primates [J].

Collier, Timothy J. ;

Kanaan, Nicholas M. ;

Kordower, Jeffrey H. .

NATURE REVIEWS NEUROSCIENCE, 2011, 12 (06) :359-366

[4] Premotor and nonmotor features of Parkinson's disease [J].

Goldman, Jennifer G. ;

Postuma, Ron .

CURRENT OPINION IN NEUROLOGY, 2014, 27 (04) :434-441

[5] Pathogenic LRRK2 mutations, through increased kinase activity, produce enlarged lysosomes with reduced degradative capacity and increase ATP13A2 expression [J].

Henry, Anastasia G. ;

Aghamohammadzadeh, Soheil ;

Samaroo, Harry ;

Chen, Yi ;

Mou, Kewa ;

Needle, Elie ;

Hirst, Warren D. .

HUMAN MOLECULAR GENETICS, 2015, 24 (21) :6013-6028

[6] Disease-Modifying Strategies for Parkinson's Disease [J].

Kalia, Lorraine V. ;

Kalia, Suneil K. ;

Lang, Anthony E. .

MOVEMENT DISORDERS, 2015, 30 (11) :1442-1450

[7]

Lindström V, 2014, IMMUNOTHERAPY-UK, V6, P141, DOI [10.2217/IMT.13.162, 10.2217/imt.13.162]

[8] Recent developments in biomarkers in Parkinson disease [J].

Schapira, Anthony H. V. .

CURRENT OPINION IN NEUROLOGY, 2013, 26 (04) :395-400

[9] Insights from late-onset familial parkinsonism on the pathogenesis of idiopathic Parkinson's disease [J].

Volta, Mattia ;

Milnerwood, Austen J. ;

Farrer, Matthew J. .

LANCET NEUROLOGY, 2015, 14 (10) :1054-1064

[10] Progressive dopaminergic alterations and mitochondrial abnormalities in LRRK2 G2019S knock-in mice [J].

Yue, M. ;

Hinkle, K. M. ;

Davies, P. ;

Trushina, E. ;

Fiesel, F. C. ;

Christenson, T. A. ;

Schroeder, A. S. ;

Zhang, L. ;

Bowles, E. ;

Behrouz, B. ;

Lincoln, S. J. ;

Beevers, J. E. ;

Milnerwood, A. J. ;

Kurti, A. ;

McLean, P. J. ;

Fryer, J. D. ;

Springer, W. ;

Dickson, D. W. ;

Farrer, M. J. ;

Melrose, H. L. .

NEUROBIOLOGY OF DISEASE, 2015, 78 :172-195

← 1 →